TORRENT PHARMACEUTICALS L vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads TORNTPHARM vs ZYDUSLIFE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability22
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

77.50
P/E ratio
23.19
18.67
P/B ratio
4.09
0.76%
Dividend yield
0.08%
₹63.92
EPS
₹50.09

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

27.40%
Return on equity
21.20%
15.00%
Return on capital
21.00%
33.00%
EBITDA margin
31.00%
15.29%
Net margin
18.87%

Growth

ZYDUSLIFE takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
16.35%
19.75%
Profit CAGR (3Y)
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.68L Cr
Market cap
₹1.18L Cr
₹13,980 Cr
Revenue
₹27,148 Cr
₹2,138 Cr
Net profit
₹5,124 Cr
1.69
Debt / equity
0.31
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
TORRENT PHARMACEUTICALS L full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.